Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lixinshui Fang
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lixinshui Fang (利心水方) is a traditional Chinese medicine formula used in various forms such as granules and decoction. It has been studied for its effects on cardiovascular conditions, particularly myocardial fibrosis. The mechanism of action is not fully elucidated but is believed to involve modulation of cardiac remodeling and improvement of heart function through multiple herbal components acting synergistically. Its use aligns with principles of traditional Chinese medicine rather than single-target pharmacology[2][1].
- Brand names
- Lixinshui Granules
- Other names
- 利心水方Lixinshui GranulesLixinshui Decoction
02
Targets
BNP (B-type natriuretic peptide)
Beyond the preview
Go deeper on Lixinshui Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lixinshui Fang.